Back to Search
JERRY SHIVER, DMD
DMD
Dentist
NPI: 1649361320Individual
Specialties, Licenses & Credentials
DentistPrimary
Dentist
Code: 122300000X
AL3702(AL)
Research & Publications (20)
ED performance improvement: process changes hospitals can make now.
PMID 18186206·Healthc Financ Manage·2007
8-other
Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge.
PMID 19403685·J Virol·2009
7-preclinical
Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus.
PMID 19070878·Virology·2009
7-preclinical
Synthetic peptide vaccines: the quest to develop peptide vaccines for influenza, HIV and Alzheimer's disease.
PMID 19400121·Adv Exp Med Biol·2009
7-preclinical
Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults.
PMID 19605598·Clin Vaccine Immunol·2009
2-rct
Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys.
PMID 19146898·Vaccine·2009
7-preclinical
PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination.
PMID 19124741·J Immunol·2009
7-preclinical
Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults.
PMID 19108693·AIDS Res Hum Retroviruses·2009
3-trial
Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans.
PMID 19620961·Nat Med·2009
3-trial
DNA gag/adenovirus type 5 (Ad5) gag and Ad5 gag/Ad5 gag vaccines induce distinct T-cell response profiles.
PMID 18524823·J Virol·2008
3-trial
The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infection.
PMID 18793788·Virology·2008
7-preclinical
Estimating the impact of vaccination on acute simian-human immunodeficiency virus/simian immunodeficiency virus infections.
PMID 18799584·J Virol·2008
7-preclinical
An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions.
PMID 18838688·Proc Natl Acad Sci U S A·2008
7-preclinical
Enhanced in vivo transgene expression and immunogenicity from plasmid vectors following electrostimulation in rodents and primates.
PMID 18472195·Vaccine·2008
7-preclinical
Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination.
PMID 18199650·J Virol·2008
8-other
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.
PMID 19012957·Lancet·2008
8-other
Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.
PMID 18433307·Clin Infect Dis·2008
3-trial
Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay.
PMID 17310936·J Acquir Immune Defic Syndr·2007
8-other
Fully synthetic carbohydrate HIV antigens designed on the logic of the 2G12 antibody.
PMID 17711286·J Am Chem Soc·2007
8-other
HIV type 1 vaccines for worldwide use: predicting in-clade and cross-clade breadth of immune responses.
PMID 17961117·AIDS Res Hum Retroviruses·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1709 PEPPERELL PKWY
OPELIKA, AL 36801 - Phone
- (334) 745-3268
Quick Facts
- NPI
- 1649361320
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile